Phase I Pharmacokinetic and Pharmacodynamic Trial of Irinotecan in Combination With Tomudex in Patients With Refractory Solid Malignancies.
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2010
At a glance
- Drugs Irinotecan (Primary) ; Raltitrexed (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 16 Feb 2010 Actual end date (Jan 2001) added as reported by ClinicalTrials.gov.
- 16 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Sep 2005 New trial record.